197 related articles for article (PubMed ID: 28214209)
21. Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer.
Hu H; Chen X; Zhou C; Li B; Yang Y; Ying X; Mao Y; Zhang Y; Zhong J; Dai J; Yu H; Wu B; Li X; Wang T; Duan S
J Clin Lab Anal; 2018 Jun; 32(5):e22370. PubMed ID: 29205508
[TBL] [Abstract][Full Text] [Related]
22. Estrogen enhances mismatch repair by induction of MLH1 expression via estrogen receptor-β.
Lu JY; Jin P; Gao W; Wang DZ; Sheng JQ
Oncotarget; 2017 Jun; 8(24):38767-38779. PubMed ID: 28404976
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of microsatellite instability, MLH1 expression and hMLH1 promoter hypermethylation in colorectal carcinomas among Tunisians patients.
Kria Ben Mahmoud L; Arfaoui A; Khiari M; Chaar I; Lounis A; Sammoud S; Ben Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
Tunis Med; 2012; 90(8-9):646-53. PubMed ID: 22987381
[TBL] [Abstract][Full Text] [Related]
24. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
Alemayehu A; Sebova K; Fridrichova I
Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
[TBL] [Abstract][Full Text] [Related]
25. Mismatch repair and treatment resistance in ovarian cancer.
Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
[TBL] [Abstract][Full Text] [Related]
26. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.
Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR
Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493
[TBL] [Abstract][Full Text] [Related]
27. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
[TBL] [Abstract][Full Text] [Related]
28. High frequency of MLH1 promoter methylation mediated by gender and age in colorectal tumors from Mexican patients.
Moreno-Ortiz JM; Jiménez-García J; Gutiérrez-Angulo M; Ayala-Madrigal ML; González-Mercado A; González-Villaseñor CO; Flores-López BA; Alvizo-Rodríguez C; Hernández-Sandoval JA; Fernández-Galindo MA; Maciel-Gutiérrez V; Ramírez-Plascencia H; Ramírez-Ramírez R
Gac Med Mex; 2021; 157(6):618-623. PubMed ID: 35108246
[TBL] [Abstract][Full Text] [Related]
29. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
[TBL] [Abstract][Full Text] [Related]
30. Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis.
Capel E; Fléjou JF; Hamelin R
Oncogene; 2007 Nov; 26(54):7596-600. PubMed ID: 17546041
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
[TBL] [Abstract][Full Text] [Related]
32. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
[TBL] [Abstract][Full Text] [Related]
33. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
[TBL] [Abstract][Full Text] [Related]
34. The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
Thomas R; Trapani D; Goodyer-Sait L; Tomkova M; Fernandez-Rozadilla C; Sahnane N; Woolley C; Davis H; Chegwidden L; Kriaucionis S; Maughan T; Leedham S; Palles C; Furlan D; Tomlinson I; Lewis A
Sci Rep; 2019 Sep; 9(1):13463. PubMed ID: 31530880
[TBL] [Abstract][Full Text] [Related]
35. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
[TBL] [Abstract][Full Text] [Related]
36. MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria.
Crucianelli F; Tricarico R; Turchetti D; Gorelli G; Gensini F; Sestini R; Giunti L; Pedroni M; Ponz de Leon M; Civitelli S; Genuardi M
Epigenetics; 2014 Oct; 9(10):1431-8. PubMed ID: 25437057
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
[TBL] [Abstract][Full Text] [Related]
38. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecutive series of patients with colorectal cancer.
Castillejo A; Hernández-Illán E; Rodriguez-Soler M; Pérez-Carbonell L; Egoavil C; Barberá VM; Castillejo MI; Guarinos C; Martínez-de-Dueñas E; Juan MJ; Sánchez-Heras AB; García-Casado Z; Ruiz-Ponte C; Brea-Fernández A; Juárez M; Bujanda L; Clofent J; Llor X; Andreu M; Castells A; Carracedo A; Alenda C; Payá A; Jover R; Soto JL
J Med Genet; 2015 Jul; 52(7):498-502. PubMed ID: 25908759
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
